Abbott Labs gets green light from regulators on St. Jude Medical acquisition worth $25 billion

ct-breaking-newsletter-logo.png
BREAKING BUSINESS ALERT
December 27, 2016
Abbott gets green light from regulators on St. Jude acquisition
Federal regulators greenlighted Abbott Laboratories’ purchase of St. Jude Medical on Tuesday after the companies agreed to divest two medical device businesses.
ADVERTISEMENT
imp?s=73742&t=newsletter&sz=1x1&li=Chicago&e=ir@globalcrossroadscapital.com&cm=001_hBYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73743&t=newsletter&sz=1x1&li=Chicago&e=ir@globalcrossroadscapital.com&cm=001_hBYYvAIB8hLfLB9Wwa9AABA8xEm
imp?s=71816&t=newsletter&sz=116x15&li=Chicago&e=ir@globalcrossroadscapital.com&cm=001_hBYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=71817&t=newsletter&sz=69x15&li=Chicago&e=ir@globalcrossroadscapital.com&cm=001_hBYYvAIB8hLfLB9Wwa9AABA8xEm
imp?s=73994&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73995&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73996&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73997&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73998&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=73999&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74000&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74001&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74002&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74003&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74004&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=74005&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413412&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413413&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413414&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413415&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413416&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413417&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413418&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm imp?s=123413419&sz=2x1&li=ChicagoTribune&e=ir@globalcrossroadscapital.com&cm=001_BYYvAIB8hLfLB9Wwa9AABA8xEm
Breaking news | Weather | Mobile site | Text alerts | Member Center | Manage subscriptions

You’re currently subscribed as globalcrossroadscapital.com. If you’d like to unsubscribe, please

Copyright 2016 Chicago Tribune Company, LLC | Privacy policy | Terms of Service

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s